Which Canadian Healthcare Stocks Could Make You Rich?

Sienna Senior Living Inc. (TSX:SIA) and two other Canadian healthcare stocks are performing very differently on the TSX. Are they worth your money?

| More on:
hospital, aged care facility

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Healthcare is big business, so every now and then it makes sense to see how it’s represented on the TSX. Three stocks have been chosen today on the basis of their overall strength as well as other filters, such as market cap, fundamentals, and dividends.

It’s interesting to see three stocks in the same field that do such totally different things. I was expecting to see similar multiples across these three healthcare stocks, so it was something of a shock to find that each one behaves completely differently from the next: one pays great dividends, while another reinvests but has high growth ahead. But are any of them worth investing in, and could they make you wealthy?

Without further ado, let’s comb through the figures and see which front-running Canadian healthcare stock might be a buy today.

Aurinia Pharmaceuticals Inc. (TSX:AUP)(NASDAQ:AUPH)

Aurinia Pharmaceuticals is overvalued at the moment, with shares going for eight times their future cash flow value. In terms of fundamentals, Aurinia Pharmaceuticals is hard to scrutinize, since its loss-making status makes calculations somewhat opaque. A P/B of around three times leaves would-be investors with a bit of a conundrum, especially if they’ve been eyeing this stock for its upside.

Speaking of upside, Aurinia Pharmaceuticals is looking at a 71.7% expected annual growth in earnings. Anyone looking at owning this stock should be aware of another positive: Aurinia Pharmaceuticals holds zero debt. This is a good indicator that future performance estimates may be accurate.

Medical Facilities Corp. (TSX:DR)

Discounted by over 50% compared to its future cash flow value, Medical Facilities has a nice and low P/E of 13.4 times earnings, further indicating good value. Its PEG of -0.5 times growth is indicative of this stock’s estimated lack of growth next year, though. Indeed, a negative figure for outlook of -26.6% expected annual growth in earnings means that this is not a stock for growth investors at present.

While a P/B of 2.4 times book looks high, this actually signals good value for the industry. Factor in a very attractive dividend yield of 7.79%, and you have a good stock for your TFSA or retirement fund.

Sienna Senior Living Inc. (TSX:SIA)

Sienna Senior Living is sending value investors mixed messages on multiples at present. It’s got a high P/E of 47.1 times earnings, but with some high growth ahead, this makes sense.

Sienna Senior Living’s P/B of 1.9 times book is low for the industry, indicating good value. All round, it’s a bit of a mixed bag of multiples, making it difficult to ascertain whether the stock is good value or not today. Looking at today’s price compared to the same time last year, we can see that it’s trading close to its 52-week low, which does seem to indicate that would-be investors would be getting good value for their money.

An expected 34.3% annual growth in earnings makes Sienna Senior Living a serious contender for growth investors, while that dividend yield of 5.41% makes for a tasty passive-income stock.

The bottom line

Sienna Senior Living and Medical Facilities both have high levels of debt, so do your homework before you invest. Both offer healthy dividends, but be sure that those yields are serviceable. Either one has the potential to line your pockets if they continue to do well. Aurinia Pharmaceuticals, meanwhile, is a healthy stock with a lot of potential upside, making this is a good pick for growth investors to consider for serious long-term capital gains.

Should you invest $1,000 in Aurinia Pharmaceuticals Inc. right now?

Before you buy stock in Aurinia Pharmaceuticals Inc., consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Aurinia Pharmaceuticals Inc. wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Investing

Start line on the highway
Dividend Stocks

Where to Allocate $7,000 in TFSA Investments in Canadian Dividend Stocks in Today’s Market

These stocks pay dividends with high yields and offer a shot at decent upside on a rebound.

Read more »

analyze data
Dividend Stocks

How I’d Allocate My $7,000 TFSA Contribution for Optimal Returns

Use the annual growth in your TFSA contribution room to boost your passive income and enjoy the returns tax-free by…

Read more »

Paper Canadian currency of various denominations
Tech Stocks

Top Canadian Value Stocks I’d Buy Today and Hold for +20 Years

Here's why undervalued Canadian stocks such as Docebo and Lululemon should be on your watchlist in 2025.

Read more »

Trans Alaska Pipeline with Autumn Colors
Energy Stocks

Enbridge Stock: Buy, Hold, or Sell Now?

Enbridge recently dropped $5 per share. Is the stock now oversold?

Read more »

stock research, analyze data
Investing

How I’d Allocate $1,000 in TSX Stocks in Today’s Market

These two defensive stocks can be excellent additions to your portfolio if you seek investments that can outperform the broader…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

How I’d Allocate My TFSA Contribution to Canadian Value Stocks This Year

I’d split my $7,000 TFSA contribution across solid dividend-paying stocks from different sectors

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Monday, April 14

Mixed commodity prices and continued trade uncertainties could keep the TSX index flat at the open today.

Read more »

Start line on the highway
Stocks for Beginners

My Top 5 Canadian Stocks for Beginning Investors

A market correction is a good time for new investors to begin their investing journey. These five Canadian stocks can…

Read more »